Please provide your email address to receive an email when new articles are posted on . Infants with bronchiolitis who are treated with high-flow oxygen therapy are less likely to require increased ...

Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...

Infant-oxygen-mask_G_174818700 Compared with standard oxygen therapy, high-flow treatments were better for infants with bronchiolotis. (HealthDay News) — High-flow oxygen therapy may be more effective ...

This was a multicenter, randomized trial comparing a "standard" therapy group of patients receiving supplemental oxygen via nasal cannula and a "high-flow" therapy group of patients receiving ...

The American College of Physicians (ACP) today released a new Clinical Guideline with recommendations for the appropriate use of high-flow nasal oxygen in hospitalized patients for initial or ...

Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...

Patients with a cluster headache, which is characterized by bouts of excruciating pain usually near the eye or temple, were more likely to report being pain-free within 15 minutes of treatment with ...

Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%. In this randomized trial of children under 16 years, nasal high-flow oxygen ...

High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen ...

Risk of secondary hematologic malignancies in patients with ovarian cancer treated with PARP inhibitors: A combined meta-analysis of seven phase III randomized controlled trials. This is an ASCO ...